查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球银屑病关节炎治疗市场规模研究与预测:按药物类型（NSAIDs,DMARDs,生物製剂,其他）,类型（处方药,OTC）,给药途径（局部,口服,注射）,区域分析2022-2029
市场调查报告书
商品编码
1152009

全球银屑病关节炎治疗市场规模研究与预测:按药物类型（NSAIDs,DMARDs,生物製剂,其他）,类型（处方药,OTC）,给药途径（局部,口服,注射）,区域分析2022-2029

Global Psoriatic Arthritis Treatment Market Size study & Forecast, by Drug Type (NSAIDs, DMARDs, Biologics, and Others), Type (Prescription, and OTC), and Route of Administration (Topical, Oral, and Injectable) and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

到 2021 年，全球银屑病关节炎治疗市场价值约为 96.1 亿美元，预计在 2022-2029 年的预测期内将以超过 7.2% 的健康增长率增长。

银屑病关节炎是发生在银屑病患者身上的一种关节炎。银屑病关节炎会导致身体关节疼痛、肿胀和僵硬。银屑病关节炎是一种自身免疫性疾病，身体的免疫系统会攻击健康细胞。主要受影响的是膝盖、脚踝、脚和手。严重的银屑病关节炎可导致永久性关节畸形。治疗选择包括类固醇、注射剂和口服药物。银屑病关节炎发病率的上升、生物製剂和生物仿製药渗透率的提高以及主要参与者的战略举措是推动市场增长的主要因素。

国家银屑病基金会估计，到 2020 年，美国将有大约 800 万人患有银屑病。另一方面，银屑病影响全世界约 1.25 亿人，约占世界人口的 2-3%。大约 30% 的银屑病患者也会患上银屑病关节炎。此外，预计新兴国家老龄化人口的增加和医疗基础设施的发展将为预测期内的市场创造良好的增长前景。然而，与治疗相关的高成本和诊断工具缺乏标准化将阻碍 2022-2029 年预测期内的市场增长。

全球银屑病关节炎治疗市场研究考虑的主要区域包括亚太地区、北美、欧洲、中美洲和南美洲以及世界其他地区。由于银屑病关节炎患病率上升以及该地区主要市场参与者的存在，北美是一个关键地区。另一方面，由于老年人口增加和医疗基础设施发展等因素，预计亚太地区在预测期内将出现显着增长。

本报告中的主要市场进入者包括:

  • AbbVie Inc.
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company.
  • Johnson & Johnson.
  • Merck & Co Inc.
  • Mylan N.V
  • Novartis AG
  • Pfizer Inc.
  • UCB S.A.

近期市场动态。

  • 2021年12月，Novartis宣布新品Cosentyx（苏金单抗）在美国获批用于治疗4岁及以上人群的活动性肠炎相关关节炎（ERA）和活动性幼年型银屑病关节炎（JPsA）适用于 2 岁及以上人群。经 FDA 批准。
  • 2022 年 1 月，美国食品和药物管理局 (FDA) 批准了 AbbVie 的 Skyligi (risankizumab-rzaa)。这种新配方旨在用于治疗活动性银屑病关节炎 (PsA) 患者。

全球银屑病关节炎治疗市场研究范围

历史数据: 2019-2020-2021

基准估计年份:2021

预测期:2022-2029

报告的收入预测、公司排名、竞争格局、增长因素、趋势

目标细分药物类型、类型、给药途径、区域

区域范围北美；欧洲；亚太地区；拉丁美洲；世界其他地区

购买研究报导报告即可免费定制（相当于长达 8 小时的分析师时间）。添加或更改国家、地区、航段范围*

这项研究的目的是定义近年来各个细分市场和国家的市场规模，并预测他们在未来几年的价值。该报告旨在捕捉被调查国家工业的定性和定量方面的情况。

它还提供了有关关键方面的详细信息，例如将定义市场未来增长的驱动因素和挑战。此外，它还包含供利益相关者投资的微观市场潜在机会，以及对主要参与者的竞争格局和产品供应的深入分析。市场的详细细分和子细分如下所述。

按药物类型

非甾体抗炎药

DMARDs

生物製品

其他

按类型

处方药

非处方药物

按给药途径

外用

口服

注射

按地区

北美

美国

加拿大

欧洲

英国

德国

法国

西班牙

意大利

欧洲其他地区

亚太地区

中国

印度

日本

澳大利亚

韩国

其他亚太地区

拉丁美洲

巴西

墨西哥

世界其他地区

目录

第一章内容提要

  • 市场快照
  • 2019-2029 年按细分市场的全球市场估计和预测
    • 银屑病关节炎治疗市场:按地区划分，2019-2029
    • 银屑病关节炎治疗市场:按药物类型分类，2019-2029
    • 银屑病关节炎治疗市场:按类型分类，2019-2029
    • 银屑病关节炎治疗市场:按给药途径，2019-2029
  • 主要趋势
  • 调查方法
  • 调查先决条件

2全球银屑病关节炎治疗市场:定义和范围

  • 调查目的
  • 市场定义和范围
    • 调查范围
    • 产业进化
  • 调查目标年份
  • 货币兑换率

3 银屑病关节炎治疗的全球市场动态

  • 银屑病关节炎治疗市场影响分析（2019-2029）
    • 市场驱动力
      • 银屑病关节炎患病率增加
      • 增加生物製剂和生物仿製药的渗透
      • 主要市场参与者的战略举措
    • 市场挑战
      • 治疗费用高
      • 诊断工具缺乏标准化
    • 市场机会
      • 老年人口增加
      • 新兴市场医疗保健基础设施的增长

4 全球银屑病关节炎治疗市场:行业分析

  • 波特五力模型
    • 供应商的议价能力
    • 买方议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争对手之间的竞争
  • 波特五力模型的未来方法（2019-2029）
  • PEST分析
    • 政治的
    • 经济的
    • 社会的
    • 技术的
  • 招商引资模式
  • 分析师结论/建议
  • 顶级投资机会
  • 关键成功策略

第 5 章风险评估:COVID-19 的影响

  • 评估 COVID-19 对行业的整体影响
  • COVID-19 之前和 COVID-19 之后的市场情景

6 按药物类型分列的全球银屑病关节炎治疗市场

  • 市场快照
  • 全球银屑病关节炎治疗市场:按药物类型分列的性能潜力分析
  • 按药物类型分列的全球银屑病关节炎治疗市场及 2019-2029 年预测
  • 全球银屑病关节炎治疗市场:细分分析
    • 非甾体抗炎药
    • DMARDs
    • 生物製品
    • 其他

7 全球银屑病关节炎治疗市场，按类型

  • 市场快照
  • 全球银屑病关节炎治疗市场:按类型划分的性能潜力分析
  • 全球银屑病关节炎治疗市场:按类型估算和预测:2019-2029
  • 全球银屑病关节炎治疗市场:细分分析
    • 处方药
    • 场外交易

8 全球银屑病关节炎治疗市场，按给药途径

  • 市场快照
  • 全球银屑病关节炎治疗市场:按给药途径、性能-潜力分析
  • 全球银屑病关节炎治疗市场:按给药途径、估计和预测:2019-2029
  • 全球银屑病关节炎治疗市场:细分分析
    • 注射
    • 口服剂
    • 局部给药

9 全球银屑病关节炎治疗市场:区域分析

  • 银屑病关节炎治疗市场，按地区划分的市场概况
  • 北美
    • 美国
      • 2019-2029 年按药物类型估算和预测
      • 按类型划分的估计和预测，2019-2029
      • 2019-2029 年各给药途径的估计和预测
    • 加拿大
  • 欧洲银屑病关节炎治疗市场概况
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 欧洲其他地区
  • 亚太地区银屑病关节炎治疗市场概况
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 韩国
    • 亚太其他地区
  • 拉丁美洲银屑病关节炎治疗市场概况
    • 巴西
    • 墨西哥
  • 世界其他地区

第 10 章 竞争信息

  • 顶级市场战略
  • 公司简介
    • AbbVie Inc.
      • 主要信息
      • 概述
      • 财务（如果有数据）
      • 产品概要
      • 近期发展状况
    • Amgen Inc.
    • Bristol-Myers Squibb Company
    • Eli Lilly And Company.
    • Johnson & Johnson.
    • Merck & Co Inc.
    • Mylan N.V
    • Novartis AG
    • Pfizer Inc.
    • UCB S.A.

第十一章调查过程

  • 调查过程
    • 数据挖掘
    • 分析
    • 市场估计
    • 验证
    • 出版物
  • 调查属性
  • 调查先决条件

表格和数字列表是虚拟的，最终可交付成果可能有所不同。

Global Psoriatic Arthritis Treatment Market is valued approximately USD 9.61 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.2% over the forecast period 2022-2029. Psoriatic Arthritis is a form of arthritis that occurs in people affected from psoriasis. Psoriatic Arthritis causes pain, swelling and stiffness in body joints. Psoriatic Arthritis is an auto immune condition in which body's immune system attacks healthy cells of the body. It mainly affects knees, ankles, feet, and hands. Severe Psoriatic Arthritis can cause permanent deformation of joints. Its treatment options include steroids, injections, and oral drugs among others. The increasing incidence of Psoriatic Arthritis and growing penetration of biological and biosimilar therapies as well as strategic initiatives from leading market players are key factors accelerating the market growth.

According to the National Psoriasis Foundation estimates - as of 2020, around 8 million individuals in US are affected by Psoriasis. Whereas, globally around 125 million people are affected by Psoriasis, witnessing for around 2-3% of the global population. In addition, approximately 30 percent individuals with psoriasis also develop psoriatic arthritis. Also, rising number of geriatric individuals and growing healthcare infrastructure in emerging markets would create lucrative growth prospectus for the market over the forecast period. However, high Cost associated with treatment and lack of standardization of diagnosis tools impede the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Psoriatic Arthritis Treatment Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading region due to rising prevalence of Psoriatic Arthritis as well as presence of leading market players in the region. Whereas Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising number of geriatric individuals as well as growing healthcare infrastructure in the region.

Major market players included in this report are:

AbbVie Inc.

Amgen Inc.

Bristol-Myers Squibb Company

Eli Lilly and Company.

Johnson & Johnson.

Merck & Co Inc.

Mylan N.V

Novartis AG

Pfizer Inc.

UCB S.A.

Recent Developments in the Market:

  • In December 2021, Novartis, received approval from US FDA for its new product Cosentyx(secukinumab) for the treatment of active enthesitis-related arthritis (ERA) in four years and older, and active juvenile psoriatic arthritis (JPsA) in patients two years and older.
  • In January 2022, The US Food and Drug Administration (FDA) approved AbbVie's Skyrizi (risankizumab-rzaa). This new formulation is intended for treatment of active psoriatic arthritis (PsA) patients.

Global Psoriatic Arthritis Treatment Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered Drug Type, Type, Route of Administration, Region

Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Type

NSAIDs

DMARDs

Biologics

Others

By Type

Prescription

OTC

By Route of Administration

Topical

Oral

Injectable

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Psoriatic Arthritis Treatment Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Psoriatic Arthritis Treatment Market, by Drug Type, 2019-2029 (USD Billion)
    • 1.2.3. Psoriatic Arthritis Treatment Market, by Type, 2019-2029 (USD Billion)
    • 1.2.4. Psoriatic Arthritis Treatment Market, by Route of Administration, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Psoriatic Arthritis Treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Psoriatic Arthritis Treatment Market Dynamics

  • 3.1. Psoriatic Arthritis Treatment Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing incidence of Psoriatic Arthritis.
      • 3.1.1.2. Growing penetration of biological and biosimilar therapies
      • 3.1.1.3. Strategic initiatives from leading market players.
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost associated with treatment.
      • 3.1.2.2. Lack of standardization of diagnosis tools.
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising number of geriatric individuals.
      • 3.1.3.2. Growing healthcare infrastructure in emerging markets.

Chapter 4. Global Psoriatic Arthritis Treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Psoriatic Arthritis Treatment Market, by Drug Type

  • 6.1. Market Snapshot
  • 6.2. Global Psoriatic Arthritis Treatment Market by Drug Type, Performance - Potential Analysis
  • 6.3. Global Psoriatic Arthritis Treatment Market Estimates & Forecasts by Drug Type 2019-2029 (USD Billion)
  • 6.4. Psoriatic Arthritis Treatment Market, Sub Segment Analysis
    • 6.4.1. NSAIDs
    • 6.4.2. DMARDs
    • 6.4.3. Biologics
    • 6.4.4. Others

Chapter 7. Global Psoriatic Arthritis Treatment Market, by Type

  • 7.1. Market Snapshot
  • 7.2. Global Psoriatic Arthritis Treatment Market by Type, Performance - Potential Analysis
  • 7.3. Global Psoriatic Arthritis Treatment Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
  • 7.4. Psoriatic Arthritis Treatment Market, Sub Segment Analysis
    • 7.4.1. Prescription
    • 7.4.2. OTC

Chapter 8. Global Psoriatic Arthritis Treatment Market, by Route of Administration

  • 8.1. Market Snapshot
  • 8.2. Global Psoriatic Arthritis Treatment Market by Route of Administration, Performance - Potential Analysis
  • 8.3. Global Psoriatic Arthritis Treatment Market Estimates & Forecasts by Route of Administration 2019-2029 (USD Billion)
  • 8.4. Psoriatic Arthritis Treatment Market, Sub Segment Analysis
    • 8.4.1. Injectable
    • 8.4.2. Oral
    • 8.4.3. Topical

Chapter 9. Global Psoriatic Arthritis Treatment Market, Regional Analysis

  • 9.1. Psoriatic Arthritis Treatment Market, Regional Market Snapshot
  • 9.2. North America Psoriatic Arthritis Treatment Market
    • 9.2.1. U.S. Psoriatic Arthritis Treatment Market
      • 9.2.1.1. Drug Type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. Route of Administration breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Psoriatic Arthritis Treatment Market
  • 9.3. Europe Psoriatic Arthritis Treatment Market Snapshot
    • 9.3.1. U.K. Psoriatic Arthritis Treatment Market
    • 9.3.2. Germany Psoriatic Arthritis Treatment Market
    • 9.3.3. France Psoriatic Arthritis Treatment Market
    • 9.3.4. Spain Psoriatic Arthritis Treatment Market
    • 9.3.5. Italy Psoriatic Arthritis Treatment Market
    • 9.3.6. Rest of Europe Psoriatic Arthritis Treatment Market
  • 9.4. Asia-Pacific Psoriatic Arthritis Treatment Market Snapshot
    • 9.4.1. China Psoriatic Arthritis Treatment Market
    • 9.4.2. India Psoriatic Arthritis Treatment Market
    • 9.4.3. Japan Psoriatic Arthritis Treatment Market
    • 9.4.4. Australia Psoriatic Arthritis Treatment Market
    • 9.4.5. South Korea Psoriatic Arthritis Treatment Market
    • 9.4.6. Rest of Asia Pacific Psoriatic Arthritis Treatment Market
  • 9.5. Latin America Psoriatic Arthritis Treatment Market Snapshot
    • 9.5.1. Brazil Psoriatic Arthritis Treatment Market
    • 9.5.2. Mexico Psoriatic Arthritis Treatment Market
  • 9.6. Rest of The World Psoriatic Arthritis Treatment Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. AbbVie Inc.
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Amgen Inc.
    • 10.2.3. Bristol-Myers Squibb Company
    • 10.2.4. Eli Lilly And Company.
    • 10.2.5. Johnson & Johnson.
    • 10.2.6. Merck & Co Inc.
    • 10.2.7. Mylan N.V
    • 10.2.8. Novartis AG
    • 10.2.9. Pfizer Inc.
    • 10.2.10. UCB S.A.

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption
  • TABLE 1. Global Psoriatic Arthritis Treatment Market, report scope
  • TABLE 2. Global Psoriatic Arthritis Treatment Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Psoriatic Arthritis Treatment Market estimates & forecasts by Drug Type 2019-2029 (USD Billion)
  • TABLE 4. Global Psoriatic Arthritis Treatment Market estimates & forecasts by Type 2019-2029 (USD Billion)
  • TABLE 5. Global Psoriatic Arthritis Treatment Market estimates & forecasts by Route of Administration 2019-2029 (USD Billion)
  • TABLE 6. Global Psoriatic Arthritis Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Psoriatic Arthritis Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Psoriatic Arthritis Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Psoriatic Arthritis Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Psoriatic Arthritis Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Psoriatic Arthritis Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Psoriatic Arthritis Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Psoriatic Arthritis Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Psoriatic Arthritis Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. Global Psoriatic Arthritis Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 17. U.S. Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. U.S. Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 20. Canada Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. Canada Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 23. UK Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. UK Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 26. Germany Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. Germany Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 29. France Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. France Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 32. Italy Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Italy Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 35. Spain Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. Spain Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 38. RoE Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. RoE Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 41. China Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. China Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 44. India Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. India Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 47. Japan Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. Japan Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 50. South Korea Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. South Korea Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 53. Australia Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. Australia Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. RoAPAC Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 59. Brazil Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Brazil Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 62. Mexico Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. Mexico Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 65. RoLA Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. RoLA Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 68. Row Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. Row Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Psoriatic Arthritis Treatment Market
  • TABLE 71. List of primary sources, used in the study of global Psoriatic Arthritis Treatment Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF TABLES

  • TABLE 1. Global Psoriatic Arthritis Treatment Market, report scope
  • TABLE 2. Global Psoriatic Arthritis Treatment Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Psoriatic Arthritis Treatment Market estimates & forecasts by Drug Type 2019-2029 (USD Billion)
  • TABLE 4. Global Psoriatic Arthritis Treatment Market estimates & forecasts by Type 2019-2029 (USD Billion)
  • TABLE 5. Global Psoriatic Arthritis Treatment Market estimates & forecasts by Route of Administration 2019-2029 (USD Billion)
  • TABLE 6. Global Psoriatic Arthritis Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Psoriatic Arthritis Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Psoriatic Arthritis Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Psoriatic Arthritis Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Psoriatic Arthritis Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Psoriatic Arthritis Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Psoriatic Arthritis Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Psoriatic Arthritis Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Psoriatic Arthritis Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. Global Psoriatic Arthritis Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 17. U.S. Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. U.S. Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 20. Canada Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. Canada Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 23. UK Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. UK Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 26. Germany Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. Germany Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 29. France Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. France Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 32. Italy Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Italy Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 35. Spain Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. Spain Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 38. RoE Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. RoE Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 41. China Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. China Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 44. India Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. India Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 47. Japan Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. Japan Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 50. South Korea Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. South Korea Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 53. Australia Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. Australia Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. RoAPAC Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 59. Brazil Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Brazil Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 62. Mexico Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. Mexico Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 65. RoLA Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. RoLA Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Psoriatic Arthritis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 68. Row Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. Row Psoriatic Arthritis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Psoriatic Arthritis Treatment Market
  • TABLE 71. List of primary sources, used in the study of global Psoriatic Arthritis Treatment Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Psoriatic Arthritis Treatment Market, research methodology
  • FIG 2. Global Psoriatic Arthritis Treatment Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Psoriatic Arthritis Treatment Market, key trends 2021
  • FIG 5. Global Psoriatic Arthritis Treatment Market, growth prospects 2022-2029
  • FIG 6. Global Psoriatic Arthritis Treatment Market, porters 5 force model
  • FIG 7. Global Psoriatic Arthritis Treatment Market, pest analysis
  • FIG 8. Global Psoriatic Arthritis Treatment Market, value chain analysis
  • FIG 9. Global Psoriatic Arthritis Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Psoriatic Arthritis Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Psoriatic Arthritis Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Psoriatic Arthritis Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Psoriatic Arthritis Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Psoriatic Arthritis Treatment Market, regional snapshot 2019 & 2029
  • FIG 15. North America Psoriatic Arthritis Treatment Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Psoriatic Arthritis Treatment Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Psoriatic Arthritis Treatment Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Psoriatic Arthritis Treatment Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Psoriatic Arthritis Treatment Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable